Visilizumab (Anti-CD3)
Product Specifications
CAS Number
219716-33-3
Target
CD markers
Applications
Transmembrane Transporters
Additionnal Information
Visilizumab (Anti-CD3) is a humanized, non-Fc receptor (FcR) -binding IgG2 monoclonal antibody (MoAb) directed against CD3 with potential immunosuppressive activity. Visilizumab has the potential to be used for ulcerative colitis and Crohn's disease research. MW : 144.62 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
ICH1176-100mg 100 mg
Anti-Mouse MHC Class II (M5/114.15.2) In Vivo Antibody - Low Endotoxin
Sign In for Pricing
View Details 
BNC882049-500 1x 500 µL
CD43 (T-Cell Marker) (SPN/2049R), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNUB2790-100 1x 100 µL
CD63 (Late Endosomes Marker) (LAMP3/2790), 0.2mg/mL
Sign In for Pricing
View Details 
BNC681927-500 1x 500 µL
SOX9 / SRY-box 9 (PCRP-SOX9-1A2), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
